Sort by
Refine Your Search
-
Employer
- Institute of Nuclear Chemistry and Technology
- Institute of Physical Chemistry, Polish Academy of Sciences
- International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences
- Nencki Institute of Experimental Biology
- University of Lodz
- University of Warsaw: Faculty of Mathematics, Informatics and Mechanics
- University of Wroclaw
- Warsaw University of Technology
-
Field
-
studies, filogenetics DESCRIPTION : A candidate has to meet the requirements of article 113 and article 116 of the Act of 20 July 2018 ‒ Law on Higher Education and Science (The Official Journal of Laws
-
months under the NCN grant OPUS 2022/45/B/ST2/01527 "Extreme QCD matter and heavy-ion phenomenology" The competition is open to each candidate who meets the requirements set out in the Higher Education and
-
International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences | Poland | 1 day ago
to develop new tools for safer and more effective surgical interventions, new therapies for eye diseases, and diagnostic methods to improve prognosis and restore vision. The main technology to be developed
-
comes with no teaching obligations and generous travel budget. Selected candidate will work on problems in the area of automata theory and logic in computer science, more specifically on topics connected
-
. Requirements Research FieldEngineering » Chemical engineeringEducation LevelPhD or equivalent Skills/Qualifications 1. ability to independently develop analysis (research) results in written and electronic form
-
of an international agreement on the equivalence of education, was issued by an authorized institution operating in an EU, OECD or EFTA Member State, was issued in another country and recognized on the basis
-
/ST4/01152, leader dr Dawid Grzegorz Lichosyt) to develop regioselective hydrofunctionalization reactions using bioinspired strategies involving non-covalent interactions. Responsibilities: Design and
-
) uses radionuclides attached to cancer-specific molecules to selectively deliver radiation to the tumor. The aim of this project is to develop novel radiobioconjugates based on anti-HER2 biomolecules